pathologythrowaway135
New Member
- Joined
- Dec 7, 2021
- Messages
- 2
- Reaction score
- 0
I am a Canadian MD/PhD student MSI3 who is interested in applying to academic pathology programs with a specific research focus. Meaning that I am looking for a pathology program with an excellent name-brand recognition in research with a strong pathology clinical training program.
Background wise, I finished my non-pathology PhD in 3 years, with a first author publication that are in the mid-low impact factor range (4-5), one top first author cancer publication (11-13) and one co-first top chemistry publication (10-11). Also I have a few co-authored publications that range in the mid-low impact factor range. I have four first author papers I am writing at the moment to round out my PhD work, two of which will go to a top therapeutics journal. I also initiated a project for COVID which the first paper (co-author) will go to a Nature sub-journal (i.e. Nature XX) and plan to send the second paper as a co-first author to the same journal.
In terms of my other accomplishments, I have a series of drugs that I developed in my PhD that are slated to begin clinical trials next year at my hospital, with a company with financial backing that is sponsoring the clinical trials. On both patents, I am the highest percentage holder, even higher than my PhD supervisor.
After my PhD, I started pathology research in bioinformatics with a former collaborator (now supervisor), and have already co-authored a paper in a top pathology journal (14-18), contributing bioinformatics data. I am also part of a team re-vamping one of the residency programs as it nearly missed accreditation, contributing my expertise from my PhD. I also do consulting work for a biotech company on the side (~5 hours a week). I was awarded multiple fellowships during my PhD for research, beyond the typical F31 (I think?) predoctoral fellowship-equivalent in my country. Finally, (I guess it might matter for the university, less so for the program), I wrote and was awarded a major grant for my lab to continue to fund my project after I left.
My university is not allowing out of country electives this year. Inter-Canadian electives are not allowed until September and there's talk that Omicron might shut that down also, depending on how bad the next wave might be. I will not be able to pursue American electives in my MSI4 year because of these restrictions.
My question is
Background wise, I finished my non-pathology PhD in 3 years, with a first author publication that are in the mid-low impact factor range (4-5), one top first author cancer publication (11-13) and one co-first top chemistry publication (10-11). Also I have a few co-authored publications that range in the mid-low impact factor range. I have four first author papers I am writing at the moment to round out my PhD work, two of which will go to a top therapeutics journal. I also initiated a project for COVID which the first paper (co-author) will go to a Nature sub-journal (i.e. Nature XX) and plan to send the second paper as a co-first author to the same journal.
In terms of my other accomplishments, I have a series of drugs that I developed in my PhD that are slated to begin clinical trials next year at my hospital, with a company with financial backing that is sponsoring the clinical trials. On both patents, I am the highest percentage holder, even higher than my PhD supervisor.
After my PhD, I started pathology research in bioinformatics with a former collaborator (now supervisor), and have already co-authored a paper in a top pathology journal (14-18), contributing bioinformatics data. I am also part of a team re-vamping one of the residency programs as it nearly missed accreditation, contributing my expertise from my PhD. I also do consulting work for a biotech company on the side (~5 hours a week). I was awarded multiple fellowships during my PhD for research, beyond the typical F31 (I think?) predoctoral fellowship-equivalent in my country. Finally, (I guess it might matter for the university, less so for the program), I wrote and was awarded a major grant for my lab to continue to fund my project after I left.
My university is not allowing out of country electives this year. Inter-Canadian electives are not allowed until September and there's talk that Omicron might shut that down also, depending on how bad the next wave might be. I will not be able to pursue American electives in my MSI4 year because of these restrictions.
My question is
- What is my competitiveness for pathology residencies that have a very strong research focus? I am interested in pursuing the path of a physician scientist.
- How can I improve my application even further? I have been studying for the STEP 1 and STEP 2 exams with the intention of taking both in June before my MSI4 year (I did not consider American residencies until starting MSI3, hence no STEP 1). I know I need to aim for a score of about 240-250 to be competitive for STEP 2 as STEP 1 is turning to a P/F score.